United States v. Edwards LifeSciences Corp. and Genesis MedTech Group Limited; Proposed Final Judgment and Competitive Impact Statement

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given pursuant to the Antitrust Procedures and Penalties Act, 15 U.S.C. 16(b)-(h) , that a proposed Final Judgment, Stipulation, and Competitive Impact Statement have been filed with the United States District Court for the District of Columbia in United States of America v. Edwards LifeSciences Corp. and Genesis MedTech Group Limited, Civil Action No. 1:26-cv-02450. On July 13, 2026, the United States filed a Complaint alleging that Edwards' acquisition of JC Medical, Inc. from Genesis violated the HSR Act, 15 U.S.C. 18a . The proposed Final Judgment, filed at the same time as the Complaint, requires Edwards to pay a civil penalty of $10 million dollars, institute an antitrust compliance program, and to provide the FTC notice prior to acquiring any part of a firm that is selling or conducting clinical trials in the United States for a transcatheter aortic valve replacement for aortic regurgitation (“TAVR-AR”) device. The proposed Final Judgment also requires Genesis to pay a civil penalty of $2 million dollars. Copies of the Complaint, proposed Final Judgment, and Competitive Impact Statement are available for inspection on the Antitrust Division's website at http://www.justice.gov/​atr and at the Office of the Clerk of the United States District Court for the District of Columbia. Copies of these materials may be obtained from the Antitrust Division upon request and payment of the copying fee set by…